Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors.
Molecular Weight:
470.24
Purity:
99.18%
CAS Number:
[2252314-46-6]
Formula:
C17H16FIN4O3
Target:
MEK|||p38 MAPK|||PERK
T78209
* VAT and and shipping costs not included. Errors and price changes excepted